Literature DB >> 21325117

Atovaquone-proguanil use in early pregnancy and the risk of birth defects.

Björn Pasternak, Anders Hviid.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325117     DOI: 10.1001/archinternmed.2010.521

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  6 in total

1.  Prophylactic use of antimalarials during pregnancy.

Authors:  Marie-Hélène Irvine; Adrienne Einarson; Pina Bozzo
Journal:  Can Fam Physician       Date:  2011-11       Impact factor: 3.275

2.  Safety of atovaquone-proguanil during pregnancy.

Authors:  Romana C Mayer; Kathrine R Tan; Julie R Gutman
Journal:  J Travel Med       Date:  2019-06-01       Impact factor: 8.490

Review 3.  Safety of antimalarial drugs exposure during early pregnancy.

Authors:  Harry Tagbor; Gifty Antwi; Joslin Dogbe
Journal:  Res Rep Trop Med       Date:  2014-06-19

4.  The safety of atovaquone-proguanil for the prevention and treatment of malaria in pregnancy: A systematic review.

Authors:  Kristin L Andrejko; Romana C Mayer; Stephanie Kovacs; Emma Slutsker; Emily Bartlett; Kathrine R Tan; Julie R Gutman
Journal:  Travel Med Infect Dis       Date:  2019-01-14       Impact factor: 20.441

5.  Advances in the treatment of malaria.

Authors:  Francesco Castelli; Lina Rachele Tomasoni; Alberto Matteelli
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-10-03       Impact factor: 2.576

6.  A survey on outcomes of accidental atovaquone-proguanil exposure in pregnancy.

Authors:  Kathrine R Tan; Jessica K Fairley; Mengxi Wang; Julie R Gutman
Journal:  Malar J       Date:  2018-05-15       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.